Literature DB >> 8084452

Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis.

J P Cristol1, B Canaud, H Rabesandratana, I Gaillard, A Serre, C Mion.   

Abstract

Leukocyte activation during haemodialysis (HD) was evaluated by reactive oxygen species (ROS) production and cell surface markers expression (CD11b: C3bi receptor and CD25: IL2 receptor). Eight end-stage renal disease patients were exposed to three dialysis phases according to a A/B/A protocol study. During phase A polysulphone (PS) membranes were used and during phase B cuprophane (CU) membranes were used. Each phase lasted 3 weeks. Timed samples were collected during the last session of each phase at 0, 15, and 30 min of HD. Flow cytometry analysis was performed both on monocytes (MO), polymorphonuclears (PMN), and lymphocytes (Ly). Hydroethydine was used as a marker of cell-ROS production. Specific monoclonal antibodies were used to analyse the cell surface markers. CU increased ROS production in PMN and MO by 10- and 2.4-fold respectively and had no significant effect on Ly. CU enhanced 16-fold CD11b expression on PMN, and increased also CD11b and CD25 expression on MO by 7- and 40-fold respectively. On the contrary, PS did not affect either ROS production or cell surface markers expression in MO, PMN, Ly. We conclude that oxydative metabolism and cell surface markers expression of PMN and MO were significantly increased with cuprophane membranes and not with polysulphone membranes, suggesting that complex cell-cell interactions were involved in membrane-related bioincompatibility phenomena.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084452

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Quantitative analysis of the regulation of leukocyte chemosensory migration by a vascular prosthetic biomaterial.

Authors:  C C Chang; S M Lieberman; P V Moghe
Journal:  J Mater Sci Mater Med       Date:  2000-06       Impact factor: 3.896

2.  Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy.

Authors:  P R Krishnaswamy; Anjali Rao; W Murali; H Sudarshan Ballal
Journal:  Indian J Clin Biochem       Date:  2006-09

Review 3.  Linking chronic kidney disease and Parkinson's disease: a literature review.

Authors:  Jesús D Meléndez-Flores; Ingrid Estrada-Bellmann
Journal:  Metab Brain Dis       Date:  2020-09-29       Impact factor: 3.584

Review 4.  Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease.

Authors:  Chih-Chien Sung; Yu-Chuan Hsu; Chun-Chi Chen; Yuh-Feng Lin; Chia-Chao Wu
Journal:  Oxid Med Cell Longev       Date:  2013-08-24       Impact factor: 6.543

5.  Evaluation of neutrophil function during hemodialysis treatment in healthy dogs under anesthesia with sevoflurane.

Authors:  Shunsuke Shimamura; Ken Kimura; Masaaki Katayama; Tadahisa Mashita; Kenichi Maeda; Saori Kobayashi; Reeko Sato; Jun Yasuda
Journal:  J Vet Med Sci       Date:  2014-08-21       Impact factor: 1.267

6.  Changes in the conformational state of hemoglobin in hemodialysed patients with chronic renal failure.

Authors:  Anna Pieniazek; Krzysztof Gwozdzinski
Journal:  Oxid Med Cell Longev       Date:  2015-03-18       Impact factor: 6.543

Review 7.  Oxidative Stress in Hemodialysis Patients: A Review of the Literature.

Authors:  Vassilios Liakopoulos; Stefanos Roumeliotis; Xenia Gorny; Evangelia Dounousi; Peter R Mertens
Journal:  Oxid Med Cell Longev       Date:  2017-09-12       Impact factor: 6.543

8.  Effect of reuse of polysulfone membrane on oxidative stress during hemodialysis.

Authors:  P Ramakrishna; E Prabhakar Reddy; M M Suchitra; A R Bitla; P V Srinivasa Rao; V Sivakumar
Journal:  Indian J Nephrol       Date:  2012-05

Review 9.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

Review 10.  Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.

Authors:  D S March; M P M Graham-Brown; C M Stover; N C Bishop; J O Burton
Journal:  Biomed Res Int       Date:  2017-01-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.